Deep Tide TechFlow News, on August 23, according to Strategic ETH Reserve's post on platform X, the Nasdaq-listed Ethereum treasury company ETHZilla (formerly 180 Life Sciences Corp.) disclosed that it has amended the previously signed securities sales agreement, which involves a prospectus supplement and the issuance of common stock in the accompanying prospectus. According to the terms of the amended sales agreement, the company will be able to raise up to $10,000,000,000 through the issuance and sale of common stock to support its ongoing purchases of ETH.
